EMJ Hematology 10 [Supplement 3] . 2022

In this issue

Haemophilia is a rare, monogenic disease that occurs from a single gene mutation and can have debilitating effects on the individual. With two subtypes, this inherited condition is currently treated with lifelong coagulation factor replacement therapy but is an ideal candidate for gene therapy management.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.